GlassScriptPhysician profile
Amy S Haney
NPI 1659333110
$5,555.36
in general payments reported to CMS, 2019-2025
31 companies · $1,024 in 2025
The $1,024 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $796 · 2020: $228 · 2021: $598 · 2022: $875 · 2023: $1,080 · 2024: $954 · 2025: $1,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,058.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,122.08 | 2019-2025 | |
| Novo Nordisk INC | $795.96 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $361.72 | 2019-2025 | |
| Glaxosmithkline, LLC. | $351.14 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $331.56 | 2019-2024 | Farxiga |
| Lilly USA, LLC | $300.23 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Merck Sharp & Dohme LLC | $267.65 | 2019-2024 | Gardasil 9, Vaxelis, Gardasil |
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.91 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $183.40 | 2023-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $165.20 | 2021-2022 | |
| Exact Sciences Corporation | $160.22 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $151.70 | 2021-2025 | Otezla, Repatha, Otezla |
| Axsome Therapeutics, INC. | $137.85 | 2023-2025 | Auvelity, Symbravo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $132.18 | 2025 | Caplyta |
| Biohaven Pharmaceutical Holding Company LTD. | $129.21 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $118.57 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.70 | 2023-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $87.17 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $76.47 | 2019-2022 | |
| Dexcom, INC. | $75.19 | 2021-2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $68.67 | 2019-2021 | |
| Scpharmaceuticals INC. | $38.37 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $32.52 | 2022-2023 | Airduo Digihaler |
| Bayer Healthcare Pharmaceuticals INC. | $30.74 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $22.94 | 2019-2021 | |
| Daiichi Sankyo INC. | $17.60 | 2025 | Injectafer |
| Xeris Pharmaceuticals, INC. | $16.89 | 2024 | Gvoke Hypopen |
| Otsuka America Pharmaceutical, INC. | $16.03 | 2024 | Rexulti |
| Shire North American Group INC | $14.86 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.73 | 2021 | |
| Allergan, INC. | $12.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Haney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.